No abstract

and statistically significant; though none of the patient demographic features or serological markers were found to be associated with the delta change in phosphate to predict high risk patients. The median recovery time of 14 days is less than what is reported in adult reviews. FCM infusions need preassessment, counselling and post infusion monitoring to assess effectiveness and recovery.

Background: Inflammatory Bowel Disease (IBD) encompasses two related but unique disorders of as yet unknown cause. The incidence has increased substantially in recent years-2.2 to 6.8/100 000 in paediatric/adolescent population worldwide.Current therapeutic goals in children and adolescents are to diagnose/ treat relapses early, improve clinical management and reduce morbidity.

No abstract

No abstract